Stem Cells http://www.stemcellsportal.com/
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


First published online November 10, 2005
Stem Cells Vol. 24 No. 4 April 2006, pp. 1113 -1120
doi:10.1634/stemcells.2005-0416; www.StemCells.com
© 2006 AlphaMed Press

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2005-0416v1
24/4/1113    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kafienah, W.
Right arrow Articles by Hollander, A. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kafienah, W.
Right arrow Articles by Hollander, A. P.

TISSUE-SPECIFIC STEM CELLS

Nucleostemin Is a Marker of Proliferating Stromal Stem Cells in Adult Human Bone Marrow

Wael Kafienah, Sanjay Mistry, Christopher Williams, Anthony P. Hollander

Academic Rheumatology, Department of Clinical Science at North Bristol, University of Bristol, Bristol, United Kingdom

Key Words. Nucleostemin • Stem cell • Bone marrow • Tissue engineering

Correspondence: Wael Kafienah, Ph.D., University of Bristol Academic Rheumatology, Department of Clinical Science at North Bristol, AMBI Research Laboratories, Avon Orthopaedic Centre, Southmead Hospital, Bristol BS10 5NB, United Kingdom. Telephone: 44-117-959-6171; Fax: 44-117-959-6187; e-mail: w.z.kafienah{at}bristol.ac.uk

Received August 26, 2005; accepted for publication November 2, 2005.
The identification of stem cell–specific proteins and the elucidation of their novel regulatory pathways may help in the development of protocols for control of their self-renewal and differentiation for cell-based therapies. Nucleostemin is a recently discovered nucleolar protein predominantly associated with proliferating rat neural and embryonic stem cells, and some human cancer cell lines. A comprehensive study of nucleostemin in human adult bone marrow stem cells is lacking. The aim of the study was to determine if nucleostemin is synthesized by adult bone marrow stem cells and to analyze its expression during their expansion and differentiation. Using a multipotential adherent population of stem cells, nucleostemin was localized to the nucleoli and occurred in 43.3% of the cells. There was a high level of expression of nucleostemin mRNA in bone marrow stem cells and this remained unchanged over time during cell expansion in culture. When bone marrow stem cells were stimulated to proliferate by fibroblast growth factor (FGF)-2, nucleostemin expression increased in a dose-dependent manner. Small interfering RNA (siRNA) knockdown of nucleostemin abolished the proliferative effect of FGF-2. When bone marrow stem cells were differentiated into chondrocytes, adipocytes, or osteocytes, nucleostemin expression was 70%–90% lower than in the undifferentiated cells retained in monolayer culture. We conclude that nucleostemin is a marker of undifferentiated human adult bone marrow stem cells and that it is involved in the regulation of proliferation of these cells.




This article has been cited by other articles:


Home page
Circ. Res.Home page
M. Tjwa and S. Dimmeler
A Nucleolar Weapon in Our Fight for Regenerating Adult Hearts: Nucleostemin and Cardiac Stem Cells
Circ. Res., July 3, 2008; 103(1): 4 - 6.
[Full Text] [PDF]


Home page
Circ. Res.Home page
S. Siddiqi, N. Gude, T. Hosoda, J. Muraski, M. Rubio, G. Emmanuel, J. Fransioli, S. Vitale, C. Parolin, D. D'Amario, et al.
Myocardial Induction of Nucleostemin in Response to Postnatal Growth and Pathological Challenge
Circ. Res., July 3, 2008; 103(1): 89 - 97.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
J. Fransioli, B. Bailey, N. A. Gude, C. T. Cottage, J. A. Muraski, G. Emmanuel, W. Wu, R. Alvarez, M. Rubio, S. Ottolenghi, et al.
Evolution of the c-kit-Positive Cell Response to Pathological Challenge in the Myocardium
Stem Cells, May 1, 2008; 26(5): 1315 - 1324.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
D. L. Troyer and M. L. Weiss
Concise Review: Wharton's Jelly-Derived Cells Are a Primitive Stromal Cell Population
Stem Cells, March 1, 2008; 26(3): 591 - 599.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
W. Kafienah, S. Mistry, M. J. Perry, G. Politopoulou, and A. P. Hollander
Pharmacological Regulation of Adult Stem Cells: Chondrogenesis Can Be Induced Using a Synthetic Inhibitor of the Retinoic Acid Receptor
Stem Cells, October 1, 2007; 25(10): 2460 - 2468.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
H. Yasumoto, L. Meng, T. Lin, Q. Zhu, and R. Y. L. Tsai
GNL3L inhibits activity of estrogen-related receptor {gamma} by competing for coactivator binding
J. Cell Sci., August 1, 2007; 120(15): 2532 - 2543.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
Q. Zhu, H. Yasumoto, and R. Y. L. Tsai
Nucleostemin Delays Cellular Senescence and Negatively Regulates TRF1 Protein Stability
Mol. Cell. Biol., December 15, 2006; 26(24): 9279 - 9290.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
C. Beekman, M. Nichane, S. De Clercq, M. Maetens, T. Floss, W. Wurst, E. Bellefroid, and J.-C. Marine
Evolutionarily Conserved Role of Nucleostemin: Controlling Proliferation of Stem/Progenitor Cells during Early Vertebrate Development
Mol. Cell. Biol., December 15, 2006; 26(24): 9291 - 9301.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS
http://www.stemcellsportal.com/
Copyright © 2006 by AlphaMed Press.